SlideShare a Scribd company logo
Kurdistan Board GEH/GIT Surgery Weekly J Club
Supervised by Prof Dr.Mohamed Alshekhani.
MBChB-CABM-FRCP-EBGH.
Background:
 GI symptoms are commonly seen in PC, 15.9 million
visits /year.
 One of these syndromes, (SIBO), is a diagnosis often
entertained in pc& gastroenterology settings.
 A dysbiosis syndrome is most often referred to as SIBO
,less as blind loop or stagnant loop syndrome.
 The syndrome first described by Faber in 1897 when he
described a case of “blind loop syndrome” in a patient
with underlying intestinal strictures.
 Prevalence stimates from 0-15.6% in healthy
individuals, with increasing prevalence with age &
medical comorbidities.4
 It is often considered in the DD owing to its nonspecific
presentation.
Background:
 SIBO can be broadly defined as excessive bacteria in
the SI,an increase in the number of bacteria in the small
bowel to >105 CFU/mL, some 103 CFU/mL.
 The clinical implications& even the diagnostic criteria
themselves, have been debated recently.
Etiology:
 There does not seem to be a single unifying underlying
etiology.
 Abnormalities in anatomy, motility, pH,immunity are all
contributors allowing for local proliferation of coliform
bacteria or penetration of oral-type bacteria.
 This dysbiosis is characterized by colonic-type bacteria
that ferment carbohydrates, leading to gas production.
 Anato risks can be intrinsic, traumatic, or iatrogenic.
 Intrinsic anatomical risk factors of SI include
obstruction, diverticula fi stulas.
 Individuals with H/O abdominal surgical intervention
can be at increased risk due to either intentional
alteration in existing anatomy (ie, Roux-en-Y) or postop
complications, including strictures adhesions, lead to
dysmotility&independently increase the risk.
Etiology:
 Primary dysmotility can be seen, but secondary
dysmotility is much more common.
 Secondary dysmotility can be a consequence of
systemic disease, irradiation, or medication use.
 systemic diseases known to alter motility & associated
with SIBO include Parkinson disease, systemic
sclerosis, hypothyroidism,diabetes mellitus.
 The increasing incidence of SIBO with age is also likely
secondary to changes in intestinal motility,
alchlorhydria &polypharmacy.
 Medications:
 Narcotics by effects on GI motility,PPI; effect on gastric
pH barrier.
 Outside classic RFs; cirrhosis, celiac, morbid obesity,
pancreatitis, ?IBS.
Clinical features:
 Often, SIBO is entertained in the DD due to the variety
of people at risk &its non-specific presentation.
 The classic presentation: steatorrhea, abdominal
bloating&weight loss, but this is an infrequent.
 More commonly, report bloating, flatulence, abd pain&
diarrhea.
 In more severe cases, patients can experience
malabsorption leading to weight loss&malnutrition.
 Patients with severe symptoms are at risk for a variety
of defi ciencies, mostly vits A, D, E, B12& iron, leading
to either macrocytic or microcytic anemia,
polyneuropathy&metabolic bone disease.
 Vitamin K is usually unaffected because it is a by-
product of bacterial metabolism.
Diagnosis:
 Because of NS symptoma & broad DD ,effective clinical
tests are essential to the diagnosis of SIBO.
 Several testing options have been extensively studied,
including therapeutic trials of antibiotics, SB
aspiration / culture& breath testing, all of which have
strengths & weaknesses.
Diagnosis:antibiotics
 A method often used is a therapeutic trial of antibiotics
due to the potential for both diagnostic&therapeutic
benefits,but if patients do not respond, the diagnosis
has not been ruled out.
 Risks:
 Antibacterial stewardship, unwanted adverse effects,
antibiotic resistance&C difficile colitis.
 No criteria to define a response to therapy, especially in
patients who have other comorbidities as IBS & patients
may have improvement,due to the effect on colonic
rather than small-bowel fermentation.
 This approach can be used after discussing these
issues with the patient.
Diagnosis:Breath testing
 The most widely available, least expensive.
 They detect the presence of methane/hydrogen, the
human body is unable to produce.
 Lactulose/glucose solutions are used as carbohydrate
substrates.
 Before testing, patients must be off antibiotics for 2
weeks, avoid high-fiber foods (ie, vegetables /coarse
breads) the day before&fast 12 hours before.
 Results can be variable owing to a variety of host
factors, such as the types and proportions of colonizing
bacteria, residual carbohydrates,the absorptive capacity
of the gut, age & sex.
 The sensitivities/specificities; 31-77% &44-100%,
respectively, leading to high false-positive rates.
 Glucose breath testing endorsed but more data needed
Diagnosis:SB Culture
 The most widely accepted test of choice
 Most aspirates are obtained from the duodenum during
upper endoscopy.
 Quantification of bacterial growth from SB aspirate is
currently the most widely accepted.
 even this test has limitations:
 Invasiveness of the upper endoscopy, time
consumption, need for sedation,cost.
 Most accept a threshold of bacterial growth >105
CFU/mL, but some 103 CFU/mL.
 Technical limitations, including esop/ oral bacterial
contamination, leading to false-positives,
 the inability of the scope to reach the distal small
bowel, leading to false-negatives.
Management:
 Antibiotics are the hallmark therapy.
 Antibioticsshown to be superior to placebo in
resolution of SIBO measured by normalization of BTs.
 the most common; ciprofloxacin, metronidazole,
neomycin, rifaximin,tracycline.
 The overall rate of breath test normalization with
antibiotics was 50% vs 10% for placebo.
 Rfaximin, had similar efficacy compared with
ciprofloxacin&metronidazole.
 Rifaximin may be preferable due to its intrinsic lack of
systemic bioavailability, but the cost of can be limiting.
 Commonly used regimens include ciprofloxacin 250 mg
orally twice daily for 7 days, metronidazole 250 mg
orally twice daily for 7 days&rifaximin 550 mg orally
twice daily for 7 days.
Management:
 In patients who have contraindications to antibiotics or
who prefer to avoid antibiotics.
 Use of elemental diet, which includes only nutrients
absorbed in the proximal small bowel, shown to lead to
breath test normalization & improvement in symptoms
in a large proportion of patients.
 Widespread use of elemental diets is unlikely given the
amount of restriction required.
 The evidence for probiotics is inconclusive at best
 Herbal &homeopathic regimens; there is a lack of
evidence to support a specific regimen.
Management:
 SIBO is often a relapsing condition given it is a
secondary process.
 A variety of predisposing factors lead to the
development of SIBO.
 Alteration of these factors is preferable (ie, removal of
intra-abdominal adhesions), but most often is not
possible.
 Recurrent infections can be treated with a repeated
antibiotic course or with alternating antibiotic regimens.
 Prokinetics promising to prevent recurrence, but more
data are needed.
Small Bowel Bacterial
Overgrowth (SBBO or SIBO)
 Bacteria and the gut
 Definition
 Symptoms
 Causes and conditions
Hydrogen Breath Testing
 QuinTron: www.quintron-usa.com
 Measures both hydrogen and methane
 Mail-in kit option
 MicroDirect: www.breathh2.com
 Measures hydrogen only
 Web site offers info on billing, coding,
reimbursement
 GI Pathology: offers mail-in kit
Testing Instructions
 No antibiotics for at least 7 days
 NPO for 12 hours before test
 NPO during test except for substrate in 6-8
ounces of water
 Avoid eating slowly digesting foods the day
before
 No smoking 30 min. before or during test
 No sleeping 30 min. before or during test
Testing Instructions
 Baseline breath sample
 Substrate (lactulose 10 grams) mixed in
6-8 ounces of water.
 Additional breath samples taken at 20
minute intervals for at least 5 additional
samples.
Interpreting Results
 Look for bi-phasic peaks in true
positives
 Early increase of at least 12 ppm
 Investigate interferences to accurate
results:
 Smoking, laxative use, last meal, antibiotic
use, previous surgeries, COPD
Treatment Options
The goal is to treat the underlying
cause(s), eradicate the bacterial
overgrowth, and nutritional support
 Antibiotic therapy
 Prokinetic agents
 Probiotics
 Nutritional support

More Related Content

What's hot

Probiotic and Prebiotic - Dr. Vishnu Biradar
Probiotic and Prebiotic - Dr. Vishnu BiradarProbiotic and Prebiotic - Dr. Vishnu Biradar
Probiotic and Prebiotic - Dr. Vishnu Biradar
amol1713
 
IBS-SIBO
IBS-SIBOIBS-SIBO
Ibs update gp_2020
Ibs update gp_2020Ibs update gp_2020
Ibs update gp_2020
ChernHaoChong
 
Role of probiotics in ICU pro and cons
Role of probiotics in ICU pro and consRole of probiotics in ICU pro and cons
Role of probiotics in ICU pro and cons
mansoor masjedi
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
ChernHaoChong
 
Faecal microbiota transplantation
Faecal microbiota transplantationFaecal microbiota transplantation
Faecal microbiota transplantation
DebinaChanuAthokpam
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Monkez M Yousif
 
Small bowel diseases
Small bowel diseasesSmall bowel diseases
Small bowel diseases
ChungKing Chia
 
Scleroderma and the GI Tract
Scleroderma and the GI TractScleroderma and the GI Tract
Scleroderma and the GI Tract
Scleroderma Foundation of Greater Chicago
 
Constipation in Elderly
Constipation in ElderlyConstipation in Elderly
Constipation in Elderly
Zin04ka Roitman
 
Kibow presentation
Kibow presentationKibow presentation
Kibow presentationALAA AWN
 
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
Vadivel Kumaran Sivasankaran
 
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Fabio Piccini
 
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
Gianfranco Tammaro
 
Functional bowel disorder
Functional bowel disorderFunctional bowel disorder
Functional bowel disorder
Deepak Singh
 
Constipation
ConstipationConstipation
Constipation
Hossam Mohamed
 

What's hot (20)

Probiotic and Prebiotic - Dr. Vishnu Biradar
Probiotic and Prebiotic - Dr. Vishnu BiradarProbiotic and Prebiotic - Dr. Vishnu Biradar
Probiotic and Prebiotic - Dr. Vishnu Biradar
 
Ibs
IbsIbs
Ibs
 
IBS-SIBO
IBS-SIBOIBS-SIBO
IBS-SIBO
 
Ibs update gp_2020
Ibs update gp_2020Ibs update gp_2020
Ibs update gp_2020
 
Role of probiotics in ICU pro and cons
Role of probiotics in ICU pro and consRole of probiotics in ICU pro and cons
Role of probiotics in ICU pro and cons
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
 
Microbiota
MicrobiotaMicrobiota
Microbiota
 
Faecal microbiota transplantation
Faecal microbiota transplantationFaecal microbiota transplantation
Faecal microbiota transplantation
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
 
Small bowel diseases
Small bowel diseasesSmall bowel diseases
Small bowel diseases
 
Biomol
BiomolBiomol
Biomol
 
Scleroderma and the GI Tract
Scleroderma and the GI TractScleroderma and the GI Tract
Scleroderma and the GI Tract
 
Constipation in Elderly
Constipation in ElderlyConstipation in Elderly
Constipation in Elderly
 
Kibow presentation
Kibow presentationKibow presentation
Kibow presentation
 
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
Irritable bowel syndrome (IBS)-Dr.S.Vadivel Kumaran.,MD(Gen.Med).,DM(Med.Gastro)
 
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
 
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
GASBARRINI A. Nutrizione Clinica e Gastroenterologia. ASMaD 2017
 
Chronic diarrhea
Chronic diarrheaChronic diarrhea
Chronic diarrhea
 
Functional bowel disorder
Functional bowel disorderFunctional bowel disorder
Functional bowel disorder
 
Constipation
ConstipationConstipation
Constipation
 

Similar to Git j club sibo 16.

Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptxDysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
VidushRatan1
 
Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Cheryl Penna
 
Diarrhea in children
Diarrhea in childrenDiarrhea in children
Diarrhea in children
Azad Haleem
 
Diarrhea and vomiting
Diarrhea and vomitingDiarrhea and vomiting
Diarrhea and vomiting
ATHIRAMOLK
 
Probiotics
ProbioticsProbiotics
Probiotics
Neel Shah
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.Shaikhani.
 
Laboratory investigations in inflammatory bowel disease
Laboratory investigations in inflammatory bowel disease Laboratory investigations in inflammatory bowel disease
Laboratory investigations in inflammatory bowel disease
deepakrsanghavi
 
Chronic diarrhoea in pediatrics
Chronic diarrhoea in pediatrics Chronic diarrhoea in pediatrics
Chronic diarrhoea in pediatrics
pranotitoshniwal
 
GORD DIET inpathophysiology dr Mokhtar.pptx
GORD  DIET inpathophysiology dr Mokhtar.pptxGORD  DIET inpathophysiology dr Mokhtar.pptx
GORD DIET inpathophysiology dr Mokhtar.pptx
AbdelrahmanMokhtar14
 
Probiotic : a treatment option in diarrhea and ibs
Probiotic : a treatment option in diarrhea and ibsProbiotic : a treatment option in diarrhea and ibs
Probiotic : a treatment option in diarrhea and ibs
Altamash momin
 
ACP Talk 20 Nov .pptx
ACP Talk 20 Nov .pptxACP Talk 20 Nov .pptx
ACP Talk 20 Nov .pptx
Dr BHARAT SABOO
 
Peptic Ulcer disease
Peptic Ulcer disease Peptic Ulcer disease
Peptic Ulcer disease
Sadasivarao Galaba
 
presentation.presentation slides by ptx
presentation.presentation slides by  ptxpresentation.presentation slides by  ptx
presentation.presentation slides by ptx
yakemichael
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
Hidayat Shariff
 
Chronic diarrhea in children
Chronic diarrhea in childrenChronic diarrhea in children
Chronic diarrhea in children
Dr M Sanjeevappa
 
colon targetting
colon targettingcolon targetting
colon targetting
ROHIT
 
Management of Neonatal Cholestasis: In dept Analysis
Management of Neonatal Cholestasis: In dept AnalysisManagement of Neonatal Cholestasis: In dept Analysis
Management of Neonatal Cholestasis: In dept Analysis
doctor350343
 
Small Intestinal Bacterial Overgrowth (SIBO)
Small Intestinal Bacterial Overgrowth (SIBO)Small Intestinal Bacterial Overgrowth (SIBO)
Small Intestinal Bacterial Overgrowth (SIBO)
Ahmed Al-Abadlah
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.
Shaikhani.
 

Similar to Git j club sibo 16. (20)

Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptxDysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
 
Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019Gahmj%2 e2014%2e019
Gahmj%2 e2014%2e019
 
Diarrhea in children
Diarrhea in childrenDiarrhea in children
Diarrhea in children
 
Dr ajay bhalla
Dr ajay bhallaDr ajay bhalla
Dr ajay bhalla
 
Diarrhea and vomiting
Diarrhea and vomitingDiarrhea and vomiting
Diarrhea and vomiting
 
Probiotics
ProbioticsProbiotics
Probiotics
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.
 
Laboratory investigations in inflammatory bowel disease
Laboratory investigations in inflammatory bowel disease Laboratory investigations in inflammatory bowel disease
Laboratory investigations in inflammatory bowel disease
 
Chronic diarrhoea in pediatrics
Chronic diarrhoea in pediatrics Chronic diarrhoea in pediatrics
Chronic diarrhoea in pediatrics
 
GORD DIET inpathophysiology dr Mokhtar.pptx
GORD  DIET inpathophysiology dr Mokhtar.pptxGORD  DIET inpathophysiology dr Mokhtar.pptx
GORD DIET inpathophysiology dr Mokhtar.pptx
 
Probiotic : a treatment option in diarrhea and ibs
Probiotic : a treatment option in diarrhea and ibsProbiotic : a treatment option in diarrhea and ibs
Probiotic : a treatment option in diarrhea and ibs
 
ACP Talk 20 Nov .pptx
ACP Talk 20 Nov .pptxACP Talk 20 Nov .pptx
ACP Talk 20 Nov .pptx
 
Peptic Ulcer disease
Peptic Ulcer disease Peptic Ulcer disease
Peptic Ulcer disease
 
presentation.presentation slides by ptx
presentation.presentation slides by  ptxpresentation.presentation slides by  ptx
presentation.presentation slides by ptx
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
 
Chronic diarrhea in children
Chronic diarrhea in childrenChronic diarrhea in children
Chronic diarrhea in children
 
colon targetting
colon targettingcolon targetting
colon targetting
 
Management of Neonatal Cholestasis: In dept Analysis
Management of Neonatal Cholestasis: In dept AnalysisManagement of Neonatal Cholestasis: In dept Analysis
Management of Neonatal Cholestasis: In dept Analysis
 
Small Intestinal Bacterial Overgrowth (SIBO)
Small Intestinal Bacterial Overgrowth (SIBO)Small Intestinal Bacterial Overgrowth (SIBO)
Small Intestinal Bacterial Overgrowth (SIBO)
 
GITj club bloating.
GITj club bloating.GITj club bloating.
GITj club bloating.
 

More from Shaikhani.

Git j club fiber in git20
Git j club fiber in git20Git j club fiber in git20
Git j club fiber in git20
Shaikhani.
 
Med j club mm covid20
Med j  club mm covid20Med j  club mm covid20
Med j club mm covid20
Shaikhani.
 
GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.
Shaikhani.
 
GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020
Shaikhani.
 
Med 5th geriatrics20
Med 5th geriatrics20Med 5th geriatrics20
Med 5th geriatrics20
Shaikhani.
 
GIT 4th abd wall pain
GIT 4th abd wall painGIT 4th abd wall pain
GIT 4th abd wall pain
Shaikhani.
 
GIT 4th endoscopy indications20
GIT 4th endoscopy indications20GIT 4th endoscopy indications20
GIT 4th endoscopy indications20
Shaikhani.
 
GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.
Shaikhani.
 
Med j club dm antithrombosis19
Med j club dm antithrombosis19Med j club dm antithrombosis19
Med j club dm antithrombosis19
Shaikhani.
 
Git 4th GC18.
Git 4th GC18.Git 4th GC18.
Git 4th GC18.
Shaikhani.
 
GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.
Shaikhani.
 
GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.
Shaikhani.
 
GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17
Shaikhani.
 
GiIT 4th CRC 2017.
GiIT 4th CRC 2017.GiIT 4th CRC 2017.
GiIT 4th CRC 2017.
Shaikhani.
 
Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.
Shaikhani.
 
GIT 4th ibd 2017
GIT 4th ibd 2017GIT 4th ibd 2017
GIT 4th ibd 2017
Shaikhani.
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017
Shaikhani.
 
Ppi seminar hiwa.
Ppi seminar hiwa.Ppi seminar hiwa.
Ppi seminar hiwa.
Shaikhani.
 
Ppi symposium araz.
Ppi symposium araz.Ppi symposium araz.
Ppi symposium araz.
Shaikhani.
 
Ppi symposium muhsin
Ppi symposium muhsinPpi symposium muhsin
Ppi symposium muhsin
Shaikhani.
 

More from Shaikhani. (20)

Git j club fiber in git20
Git j club fiber in git20Git j club fiber in git20
Git j club fiber in git20
 
Med j club mm covid20
Med j  club mm covid20Med j  club mm covid20
Med j club mm covid20
 
GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.GIT J Club IBD- sexual dysfunction20.
GIT J Club IBD- sexual dysfunction20.
 
GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020GIT J Club IBD- pregnancy2020
GIT J Club IBD- pregnancy2020
 
Med 5th geriatrics20
Med 5th geriatrics20Med 5th geriatrics20
Med 5th geriatrics20
 
GIT 4th abd wall pain
GIT 4th abd wall painGIT 4th abd wall pain
GIT 4th abd wall pain
 
GIT 4th endoscopy indications20
GIT 4th endoscopy indications20GIT 4th endoscopy indications20
GIT 4th endoscopy indications20
 
GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.GIT J Club from UEG Week 2018.
GIT J Club from UEG Week 2018.
 
Med j club dm antithrombosis19
Med j club dm antithrombosis19Med j club dm antithrombosis19
Med j club dm antithrombosis19
 
Git 4th GC18.
Git 4th GC18.Git 4th GC18.
Git 4th GC18.
 
GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.GIT J Club IBS NEJM17.
GIT J Club IBS NEJM17.
 
GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.GIT 4th indication for upper GI endoscopy.
GIT 4th indication for upper GI endoscopy.
 
GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17
 
GiIT 4th CRC 2017.
GiIT 4th CRC 2017.GiIT 4th CRC 2017.
GiIT 4th CRC 2017.
 
Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.Git j club colonoscopy mistakes.
Git j club colonoscopy mistakes.
 
GIT 4th ibd 2017
GIT 4th ibd 2017GIT 4th ibd 2017
GIT 4th ibd 2017
 
GIT 4th IBS 2017
GIT 4th IBS 2017GIT 4th IBS 2017
GIT 4th IBS 2017
 
Ppi seminar hiwa.
Ppi seminar hiwa.Ppi seminar hiwa.
Ppi seminar hiwa.
 
Ppi symposium araz.
Ppi symposium araz.Ppi symposium araz.
Ppi symposium araz.
 
Ppi symposium muhsin
Ppi symposium muhsinPpi symposium muhsin
Ppi symposium muhsin
 

Recently uploaded

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 

Git j club sibo 16.

  • 1. Kurdistan Board GEH/GIT Surgery Weekly J Club Supervised by Prof Dr.Mohamed Alshekhani. MBChB-CABM-FRCP-EBGH.
  • 2.
  • 3. Background:  GI symptoms are commonly seen in PC, 15.9 million visits /year.  One of these syndromes, (SIBO), is a diagnosis often entertained in pc& gastroenterology settings.  A dysbiosis syndrome is most often referred to as SIBO ,less as blind loop or stagnant loop syndrome.  The syndrome first described by Faber in 1897 when he described a case of “blind loop syndrome” in a patient with underlying intestinal strictures.  Prevalence stimates from 0-15.6% in healthy individuals, with increasing prevalence with age & medical comorbidities.4  It is often considered in the DD owing to its nonspecific presentation.
  • 4. Background:  SIBO can be broadly defined as excessive bacteria in the SI,an increase in the number of bacteria in the small bowel to >105 CFU/mL, some 103 CFU/mL.  The clinical implications& even the diagnostic criteria themselves, have been debated recently.
  • 5. Etiology:  There does not seem to be a single unifying underlying etiology.  Abnormalities in anatomy, motility, pH,immunity are all contributors allowing for local proliferation of coliform bacteria or penetration of oral-type bacteria.  This dysbiosis is characterized by colonic-type bacteria that ferment carbohydrates, leading to gas production.  Anato risks can be intrinsic, traumatic, or iatrogenic.  Intrinsic anatomical risk factors of SI include obstruction, diverticula fi stulas.  Individuals with H/O abdominal surgical intervention can be at increased risk due to either intentional alteration in existing anatomy (ie, Roux-en-Y) or postop complications, including strictures adhesions, lead to dysmotility&independently increase the risk.
  • 6. Etiology:  Primary dysmotility can be seen, but secondary dysmotility is much more common.  Secondary dysmotility can be a consequence of systemic disease, irradiation, or medication use.  systemic diseases known to alter motility & associated with SIBO include Parkinson disease, systemic sclerosis, hypothyroidism,diabetes mellitus.  The increasing incidence of SIBO with age is also likely secondary to changes in intestinal motility, alchlorhydria &polypharmacy.  Medications:  Narcotics by effects on GI motility,PPI; effect on gastric pH barrier.  Outside classic RFs; cirrhosis, celiac, morbid obesity, pancreatitis, ?IBS.
  • 7. Clinical features:  Often, SIBO is entertained in the DD due to the variety of people at risk &its non-specific presentation.  The classic presentation: steatorrhea, abdominal bloating&weight loss, but this is an infrequent.  More commonly, report bloating, flatulence, abd pain& diarrhea.  In more severe cases, patients can experience malabsorption leading to weight loss&malnutrition.  Patients with severe symptoms are at risk for a variety of defi ciencies, mostly vits A, D, E, B12& iron, leading to either macrocytic or microcytic anemia, polyneuropathy&metabolic bone disease.  Vitamin K is usually unaffected because it is a by- product of bacterial metabolism.
  • 8. Diagnosis:  Because of NS symptoma & broad DD ,effective clinical tests are essential to the diagnosis of SIBO.  Several testing options have been extensively studied, including therapeutic trials of antibiotics, SB aspiration / culture& breath testing, all of which have strengths & weaknesses.
  • 9. Diagnosis:antibiotics  A method often used is a therapeutic trial of antibiotics due to the potential for both diagnostic&therapeutic benefits,but if patients do not respond, the diagnosis has not been ruled out.  Risks:  Antibacterial stewardship, unwanted adverse effects, antibiotic resistance&C difficile colitis.  No criteria to define a response to therapy, especially in patients who have other comorbidities as IBS & patients may have improvement,due to the effect on colonic rather than small-bowel fermentation.  This approach can be used after discussing these issues with the patient.
  • 10. Diagnosis:Breath testing  The most widely available, least expensive.  They detect the presence of methane/hydrogen, the human body is unable to produce.  Lactulose/glucose solutions are used as carbohydrate substrates.  Before testing, patients must be off antibiotics for 2 weeks, avoid high-fiber foods (ie, vegetables /coarse breads) the day before&fast 12 hours before.  Results can be variable owing to a variety of host factors, such as the types and proportions of colonizing bacteria, residual carbohydrates,the absorptive capacity of the gut, age & sex.  The sensitivities/specificities; 31-77% &44-100%, respectively, leading to high false-positive rates.  Glucose breath testing endorsed but more data needed
  • 11. Diagnosis:SB Culture  The most widely accepted test of choice  Most aspirates are obtained from the duodenum during upper endoscopy.  Quantification of bacterial growth from SB aspirate is currently the most widely accepted.  even this test has limitations:  Invasiveness of the upper endoscopy, time consumption, need for sedation,cost.  Most accept a threshold of bacterial growth >105 CFU/mL, but some 103 CFU/mL.  Technical limitations, including esop/ oral bacterial contamination, leading to false-positives,  the inability of the scope to reach the distal small bowel, leading to false-negatives.
  • 12. Management:  Antibiotics are the hallmark therapy.  Antibioticsshown to be superior to placebo in resolution of SIBO measured by normalization of BTs.  the most common; ciprofloxacin, metronidazole, neomycin, rifaximin,tracycline.  The overall rate of breath test normalization with antibiotics was 50% vs 10% for placebo.  Rfaximin, had similar efficacy compared with ciprofloxacin&metronidazole.  Rifaximin may be preferable due to its intrinsic lack of systemic bioavailability, but the cost of can be limiting.  Commonly used regimens include ciprofloxacin 250 mg orally twice daily for 7 days, metronidazole 250 mg orally twice daily for 7 days&rifaximin 550 mg orally twice daily for 7 days.
  • 13. Management:  In patients who have contraindications to antibiotics or who prefer to avoid antibiotics.  Use of elemental diet, which includes only nutrients absorbed in the proximal small bowel, shown to lead to breath test normalization & improvement in symptoms in a large proportion of patients.  Widespread use of elemental diets is unlikely given the amount of restriction required.  The evidence for probiotics is inconclusive at best  Herbal &homeopathic regimens; there is a lack of evidence to support a specific regimen.
  • 14. Management:  SIBO is often a relapsing condition given it is a secondary process.  A variety of predisposing factors lead to the development of SIBO.  Alteration of these factors is preferable (ie, removal of intra-abdominal adhesions), but most often is not possible.  Recurrent infections can be treated with a repeated antibiotic course or with alternating antibiotic regimens.  Prokinetics promising to prevent recurrence, but more data are needed.
  • 15. Small Bowel Bacterial Overgrowth (SBBO or SIBO)  Bacteria and the gut  Definition  Symptoms  Causes and conditions
  • 16. Hydrogen Breath Testing  QuinTron: www.quintron-usa.com  Measures both hydrogen and methane  Mail-in kit option  MicroDirect: www.breathh2.com  Measures hydrogen only  Web site offers info on billing, coding, reimbursement  GI Pathology: offers mail-in kit
  • 17. Testing Instructions  No antibiotics for at least 7 days  NPO for 12 hours before test  NPO during test except for substrate in 6-8 ounces of water  Avoid eating slowly digesting foods the day before  No smoking 30 min. before or during test  No sleeping 30 min. before or during test
  • 18. Testing Instructions  Baseline breath sample  Substrate (lactulose 10 grams) mixed in 6-8 ounces of water.  Additional breath samples taken at 20 minute intervals for at least 5 additional samples.
  • 19. Interpreting Results  Look for bi-phasic peaks in true positives  Early increase of at least 12 ppm  Investigate interferences to accurate results:  Smoking, laxative use, last meal, antibiotic use, previous surgeries, COPD
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Treatment Options The goal is to treat the underlying cause(s), eradicate the bacterial overgrowth, and nutritional support  Antibiotic therapy  Prokinetic agents  Probiotics  Nutritional support

Editor's Notes

  1. Ask: How many are familiar with? How many know if your physicians are testing for?
  2. Symptoms Abdominal pain or discomfort Bloating/abdominal distention Constipation Diarrhea Extra-bowel symptoms – fatigue, headache, backache, muscle pain, sleep disturbance Causes: Genetic – runs in families (inflammatory process or serotonin related) Inflammatory – activation of immune system – on-going low-grade inflammatory process – affects GI motor and sensory function Neurological – brain/gut connection, psychological factors Infectious – 10 - 20% of patients can link to a gut infection that precipitated IBS – food poisoning, traveler’s diarrhea Treatment: Whole patient assessment (education, goals/expectations, stress, other illnesses, support, psychological) Fiber, dietary interventions, tegaserod (Zelnorm off market), or Amitiza (lubiprostone) for constipation, Imodium (loperamide) or Lotronex (alosetron) for diarrhea, pain treatment - antispasmodic (anticholinergic) medication
  3. Symptoms Abdominal pain or discomfort Bloating/abdominal distention Constipation Diarrhea Extra-bowel symptoms – fatigue, headache, backache, muscle pain, sleep disturbance Causes: Genetic – runs in families (inflammatory process or serotonin related) Inflammatory – activation of immune system – on-going low-grade inflammatory process – affects GI motor and sensory function Neurological – brain/gut connection, psychological factors Infectious – 10 - 20% of patients can link to a gut infection that precipitated IBS – food poisoning, traveler’s diarrhea Treatment: Whole patient assessment (education, goals/expectations, stress, other illnesses, support, psychological) Fiber, dietary interventions, tegaserod (Zelnorm off market), or Amitiza (lubiprostone) for constipation, Imodium (loperamide) or Lotronex (alosetron) for diarrhea, pain treatment - antispasmodic (anticholinergic) medication
  4. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  5. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  6. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  7. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  8. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  9. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  10. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  11. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  12. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  13. Perform blood tests to check for anemia and erythrocyte sedimentation rate (ESR) to check for inflammation Elevated thyroid – diarrhea Low Thyroid – constipation Warning Signs: Blood in stool Constant diarrhea Fever Diarrhea at night Weight loss Age over 50 years – consider colonoscopy Vomiting
  14. Normal Gut: Acid in the stomach kills most of the bacteria we ingest. Bacteria is normally only found in the colon, the proximal small intestine (duodenum and jejunum) has few to no bacteria. When bacteria metabolize carbs (fermentation), acids, water and gases are produced. The major gases are carbon dioxide and hydrogen. Only bacteria can produce hydrogen and methane. Definition: SIBO is a syndrome that involves excessive numbers of bacteria growing in the small intestine. The large numbers of bacteria compete for nutrients with the person who has the condition. As a result, the person with the condition may not absorb enough nutrients. Mark Pimentel, MD, “guru” of SIBO. Author of book “A New IBS Solution” – states as many as 84% of IBS suffers have an abnormal lactulose breath test. Symptoms: In addition to IBS symptoms - malabsorptive symptoms: anemia, weight loss, fatty/floating stool (steattorrhea)         Causes & Conditions: Previous intestinal infection (food poisoning, traveler’s diarrhea) Achlorhdria or hypochlorhydria caused by surgical interventions or prolonged use of PPI’s         Short bowel syndrome         Intestinal obstruction         Diverticulosis (duodenal or jejunal)         Dysmotility from various causes         Crohn’s disease         Chronic pancreatitis         Cirrhosis Immunodeficiency syndromes - lupus, scleroderma
  15. CPT Code: 91065 (hydrogen breath test). It is a laboratory test, usually done in office setting (or OBE) CLIA waived Reimbursement varies $50 - $90. Costs involved: Machine (one time) or kit (each test), substrate (lactulose), staff cost, cardboard tube
  16. Second peak usually larger than 1st – 12-20 ppm increase May need to extend test up to 3 hours to obtain 2nd peak If no 2nd peak, can be due to antibiotic use, increased acid in colon Peaks may merge.
  17. Antibiotics: Rifaximin, neomycin, erythromycin, flagyl, Augmentin Prokinetic Agents: Erythromycin, Zelnorm, Amitiza Probiotics: Align, FloraQ Nutritional Support Don’ts (Avoid) Foods in which bacteria thrive – hard-to-digest sugars High amounts of carbohydrates Sugar substitutes – i.e. sorbitol - Splenda – humans are unable to digest, so not absorbed, so bacteria feed on it and replicate Avoid sugar-free gum Fructose found in fruits (corn syrup) High fiber diets Frequent meals High residue meals Do’s: Moderate amounts of fiber found in fruits and vegetables Easily digestible foods (don’t leave much behind) – low residue Three meals a day – avoid snacking (allows “cleansing waves”) Adequate fluid intake Low carb diet that limits lactose (FYI – hydrogen breath testing also tests for lactose intolerance when lactose is the substrate) Potatoes, pasta, rice, bread and cereals are OK because they are absorbed high up in the small intestine – white bread is better!